BACKGROUND: Despite suppression of the human immunodeficiency virus type 1 (HIV-1) load by highly active antiretroviral therapy (HAART), recovery of CD4+ T cell counts can be impaired. We investigated whether this impairment may be associated with hyporesponsiveness of T cells to gamma-chain (gammac) cytokines known to influence T cell homeostasis. METHODS: The responsiveness of T cells to interleukin (IL)-2, IL-7, and IL-15 was determined by assessing cytokine-induced phosphorylation of the signal transducer and activator of transcription 5 (STAT5) in peripheral T cells obtained from 118 HIV-positive subjects and 13 HIV-negative subjects. RESULTS: The responsiveness of T cells to interleukin (IL)-7 but not to IL-2 or IL-15 was lower among HIV-positive subjects than among HIV-negative subjects. Among subjects with viral load suppression, the degree of IL-7 responsiveness (1) correlated with naive CD4+ T cell counts and was a better immune correlate of the prevailing CD4+ T cell count than were levels of human leukocyte antigen-DR1 or programmed death-1, which are predictors of T cell homeostasis during HIV infection; and (2) was greater in subjects with complete (i.e., attainment of >or=500 CD4+ T cells/mm3>or=5 years after initiation of HAART) versus incomplete immunologic responses. The correlation between plasma levels of IL-7 and CD4+ T cell counts during HAART was maximal in subjects with increased IL-7 responsiveness. CONCLUSIONS: Responsiveness of T cells to IL-7 is associated with higher CD4+ T cell counts during HAART and thus may be a determinant of the extent of immune reconstitution.
BACKGROUND: Despite suppression of the humanimmunodeficiency virus type 1 (HIV-1) load by highly active antiretroviral therapy (HAART), recovery of CD4+ T cell counts can be impaired. We investigated whether this impairment may be associated with hyporesponsiveness of T cells to gamma-chain (gammac) cytokines known to influence T cell homeostasis. METHODS: The responsiveness of T cells to interleukin (IL)-2, IL-7, and IL-15 was determined by assessing cytokine-induced phosphorylation of the signal transducer and activator of transcription 5 (STAT5) in peripheral T cells obtained from 118 HIV-positive subjects and 13 HIV-negative subjects. RESULTS: The responsiveness of T cells to interleukin (IL)-7 but not to IL-2 or IL-15 was lower among HIV-positive subjects than among HIV-negative subjects. Among subjects with viral load suppression, the degree of IL-7 responsiveness (1) correlated with naive CD4+ T cell counts and was a better immune correlate of the prevailing CD4+ T cell count than were levels of human leukocyte antigen-DR1 or programmed death-1, which are predictors of T cell homeostasis during HIV infection; and (2) was greater in subjects with complete (i.e., attainment of >or=500 CD4+ T cells/mm3>or=5 years after initiation of HAART) versus incomplete immunologic responses. The correlation between plasma levels of IL-7 and CD4+ T cell counts during HAART was maximal in subjects with increased IL-7 responsiveness. CONCLUSIONS: Responsiveness of T cells to IL-7 is associated with higher CD4+ T cell counts during HAART and thus may be a determinant of the extent of immune reconstitution.
Authors: L Teixeira; H Valdez; J M McCune; R A Koup; A D Badley; M K Hellerstein; L A Napolitano; D C Douek; G Mbisa; S Deeks; J M Harris; J D Barbour; B H Gross; I R Francis; R Halvorsen; R Asaad; M M Lederman Journal: AIDS Date: 2001-09-28 Impact factor: 4.177
Authors: James J Kohler; Daniel L Tuttle; Carter R Coberley; John W Sleasman; Maureen M Goodenow Journal: J Leukoc Biol Date: 2003-03 Impact factor: 4.962
Authors: T J Fry; E Connick; J Falloon; M M Lederman; D J Liewehr; J Spritzler; S M Steinberg; L V Wood; R Yarchoan; J Zuckerman; A Landay; C L Mackall Journal: Blood Date: 2001-05-15 Impact factor: 22.113
Authors: Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks Journal: J Infect Dis Date: 2003-04-23 Impact factor: 5.226
Authors: E Florence; J Lundgren; C Dreezen; M Fisher; O Kirk; A Blaxhult; G Panos; C Katlama; S Vella; A Phillips Journal: HIV Med Date: 2003-07 Impact factor: 3.180
Authors: Jessica N Hodge; Sharat Srinivasula; Zonghui Hu; Sarah W Read; Brian O Porter; Insook Kim; Joann M Mican; Chang Paik; Paula Degrange; Michele Di Mascio; Irini Sereti Journal: Blood Date: 2011-07-21 Impact factor: 22.113
Authors: M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella Journal: J Immunol Date: 2015-03-13 Impact factor: 5.422
Authors: J F Suarez; R Rosa; M A Lorio; M I Morris; L M Abbo; J Simkins; G Guerra; D Roth; W L Kupin; A Mattiazzi; G Ciancio; L J Chen; G W Burke; M J Goldstein; P Ruiz; J F Camargo Journal: Am J Transplant Date: 2016-04-04 Impact factor: 8.086